- Home
- PBYI vs ARQ Comparison
PBYI vs ARQ Comparison
Compare PBYI & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- ARQ
- Stock Information
- Founded
- PBYI 2010
- ARQ 1996
- Country
- PBYI United States
- ARQ United States
- Employees
- PBYI N/A
- ARQ N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- ARQ
- Sector
- PBYI Health Care
- ARQ
- Exchange
- PBYI Nasdaq
- ARQ NYSE
- Market Cap
- PBYI 167.3M
- ARQ 155.3M
- IPO Year
- PBYI N/A
- ARQ N/A
- Fundamental
- Price
- PBYI $3.24
- ARQ $4.86
- Analyst Decision
- PBYI Strong Buy
- ARQ Strong Buy
- Analyst Count
- PBYI 1
- ARQ 1
- Target Price
- PBYI $7.00
- ARQ $8.00
- AVG Volume (30 Days)
- PBYI 347.1K
- ARQ 194.8K
- Earning Date
- PBYI 07-31-2025
- ARQ 08-11-2025
- Dividend Yield
- PBYI N/A
- ARQ N/A
- EPS Growth
- PBYI 143.51
- ARQ N/A
- EPS
- PBYI 0.77
- ARQ N/A
- Revenue
- PBYI $232,709,000.00
- ARQ $114,466,000.00
- Revenue This Year
- PBYI N/A
- ARQ $10.91
- Revenue Next Year
- PBYI N/A
- ARQ $32.95
- P/E Ratio
- PBYI $4.40
- ARQ N/A
- Revenue Growth
- PBYI 2.68
- ARQ 14.33
- 52 Week Low
- PBYI $2.23
- ARQ $3.34
- 52 Week High
- PBYI $4.13
- ARQ $8.11
- Technical
- Relative Strength Index (RSI)
- PBYI 50.17
- ARQ 50.51
- Support Level
- PBYI $3.38
- ARQ $4.95
- Resistance Level
- PBYI $3.70
- ARQ $5.45
- Average True Range (ATR)
- PBYI 0.18
- ARQ 0.22
- MACD
- PBYI -0.03
- ARQ -0.07
- Stochastic Oscillator
- PBYI 35.82
- ARQ 5.71
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.